The J-curve between blood pressure and coronary artery disease or essential hypertension: exactly how essential?
Messerli and Panjrath
J Am Coll Cardiol 2009;54:1827-1834.
ABSTRACT
| FULL TEXT
Baseline heart rate, antihypertensive treatment, and prevention of cardiovascular outcomes in ASCOT (Anglo-Scandinavian Cardiac Outcomes Trial).
Poulter et al.
J Am Coll Cardiol 2009;54:1154-1161.
ABSTRACT
| FULL TEXT
Beta-blockers for hypertension: Are they going out of style?
CHE et al.
Cleveland Clinic Journal of Medicine 2009;76:533-542.
ABSTRACT
| FULL TEXT
Effects of Dietary Sodium Reduction on Blood Pressure in Subjects With Resistant Hypertension: Results From a Randomized Trial
Pimenta et al.
Hypertension 2009;54:475-481.
ABSTRACT
| FULL TEXT
The Hypertension Paradox -- More Uncontrolled Disease despite Improved Therapy
Chobanian
NEJM 2009;361:878-887.
FULL TEXT
CACNA1C Gene Polymorphisms, Cardiovascular Disease Outcomes, and Treatment Response
Beitelshees et al.
Circ Cardiovasc Genet 2009;2:362-370.
ABSTRACT
| FULL TEXT
{beta}-Blocker Use for the Stages of Heart Failure
Klapholz
Mayo Clin Proc. 2009;84:718-729.
ABSTRACT
| FULL TEXT
Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide: A Randomized Clinical Trial
Calhoun et al.
Hypertension 2009;54:32-39.
ABSTRACT
| FULL TEXT
Pulse pressure and risk of cardiovascular outcomes in patients with hypertension and coronary artery disease: an INternational VErapamil SR-trandolapril STudy (INVEST) analysis
Bangalore et al.
Eur Heart J 2009;30:1395-1401.
ABSTRACT
| FULL TEXT
Response to Letter by Barrios and Escobar
Pepine et al.
Stroke 2009;40:e470-e470.
FULL TEXT
Diabetes induces and calcium channel blockers prevent cardiac expression of proapoptotic thioredoxin-interacting protein
Chen et al.
Am. J. Physiol. Endocrinol. Metab. 2009;296:E1133-E1139.
ABSTRACT
| FULL TEXT
Blood pressure responder rates versus goal rates: which metric matters?
Basile
Ther Adv Cardiovasc Dis 2009;3:157-174.
ABSTRACT
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis
Verdecchia et al.
Eur Heart J 2009;30:679-688.
ABSTRACT
| FULL TEXT
Prevention of risk factors: beta-blockade and hypertension
Mancia
Eur Heart J Suppl 2009;11:A3-A8.
ABSTRACT
| FULL TEXT
Standards of Medical Care in Diabetes--2009
American Diabetes Association
Diabetes Care 2009;32:S13-S61.
FULL TEXT
CHAPTER 13 Hypertension
Kjeldsen et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT
| FULL TEXT
CHAPTER 17 Chronic Ischaemic Heart Disease
Crea et al.
ESC Textbook of Cardiovascular Medicine 2009;2:med-9780199566990-chapter-med-9780199566990-chapter.
ABSTRACT
| FULL TEXT
Does It Matter How Hypertension Is Controlled?
Chobanian
NEJM 2008;359:2485-2488.
FULL TEXT
Resistant Hypertension An Overview of Evaluation and Treatment.
Sarafidis and Bakris
J Am Coll Cardiol 2008;52:1749-1757.
ABSTRACT
| FULL TEXT
Do men and women respond differently to blood pressure-lowering treatment? Results of prospectively designed overviews of randomized trials
Turnbull et al.
Eur Heart J 2008;29:2669-2680.
ABSTRACT
| FULL TEXT
American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two
Bloomgarden
Diabetes Care 2008;31:2222-2229.
FULL TEXT
Relation of Beta-Blocker-Induced Heart Rate Lowering and Cardioprotection in Hypertension
Bangalore et al.
J Am Coll Cardiol 2008;52:1482-1489.
ABSTRACT
| FULL TEXT
Beta-Blockers for Primary Prevention of Heart Failure in Patients With Hypertension: Insights From a Meta-Analysis
Bangalore et al.
J Am Coll Cardiol 2008;52:1062-1072.
ABSTRACT
| FULL TEXT
Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics
Johnson
Circulation 2008;118:1383-1393.
FULL TEXT
Which patients would benefit the most from the perindopril-amlodipine combination?
Danchin
Eur Heart J Suppl 2008;10:G29-G35.
ABSTRACT
| FULL TEXT
Characterization of Resistant Hypertension: Association Between Resistant Hypertension, Aldosterone, and Persistent Intravascular Volume Expansion
Gaddam et al.
Arch Intern Med 2008;168:1159-1164.
ABSTRACT
| FULL TEXT
Risk/Benefit Assessment of {beta}-Blockers and Diuretics Precludes Their Use for First-Line Therapy in Hypertension
Messerli et al.
Circulation 2008;117:2706-2715.
FULL TEXT
Impact of resting heart rate on outcomes in hypertensive patients with coronary artery disease: findings from the INternational VErapamil-SR/trandolapril STudy (INVEST)
Kolloch et al.
Eur Heart J 2008;29:1327-1334.
ABSTRACT
| FULL TEXT
Trials That Matter: The Effect of a Fixed-Dose Combination of an Angiotensin-Converting Enzyme Inhibitor and a Diuretic on the Complications of Type 2 Diabetes
Bakris and Berkwits
ANN INTERN MED 2008;148:400-401.
FULL TEXT
Editorial: The new European Society of Hypertension/European Society of Cardiology (ESH/ESC) Guidelines
Mancia and Grassi
Ther Adv Cardiovasc Dis 2008;2:5-12.
Metabolic and Clinical Outcomes in Nondiabetic Individuals With the Metabolic Syndrome Assigned to Chlorthalidone, Amlodipine, or Lisinopril as Initial Treatment for Hypertension: A report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Black et al.
Diabetes Care 2008;31:353-360.
ABSTRACT
| FULL TEXT
Predicting Stroke Risk in Hypertensive Patients With Coronary Artery Disease: A Report From the INVEST
Coca et al.
Stroke 2008;39:343-348.
ABSTRACT
| FULL TEXT
Should We Target the Sympathetic Nervous System in the Treatment of Obesity-Associated Hypertension?
Biaggioni
Hypertension 2008;51:168-171.
FULL TEXT
Diastolic Pressure in Type 2 Diabetes: Can target systolic pressure be reached without "diastolic hypotension"?
Osher and Stern
Diabetes Care 2008;31:S249-S254.
ABSTRACT
| FULL TEXT
Beta-blocker therapy in hypertension: a need to pause and reflect.
Giles et al.
J Am Coll Cardiol 2008;51:516-517.
FULL TEXT
Standards of Medical Care in Diabetes--2008
American Diabetes Association
Diabetes Care 2008;31:S12-S54.
FULL TEXT
Race and Ethnicity in Trials of Antihypertensive Therapy to Prevent Cardiovascular Outcomes: A Systematic Review
Park and Taylor
Ann Fam Med 2007;5:444-452.
ABSTRACT
| FULL TEXT
Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy
Cohen et al.
Neurology 2007;69:668-675.
ABSTRACT
| FULL TEXT
REPRINT Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Rosendorff et al.
Hypertension 2007;50:e28-e55.
FULL TEXT
Blood Pressure Control and Improved Cardiovascular Outcomes in the International Verapamil SR-Trandolapril Study
Mancia et al.
Hypertension 2007;50:299-305.
ABSTRACT
| FULL TEXT
Hypertension Treatment: How Important Is Consistency of Effect?
Sica
Hypertension 2007;50:287-288.
FULL TEXT
{beta}-Blockers and Progression of Coronary Atherosclerosis: Pooled Analysis of 4 Intravascular Ultrasonography Trials
Sipahi et al.
ANN INTERN MED 2007;147:10-18.
ABSTRACT
| FULL TEXT
2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)
Authors/Task Force Members: et al.
Eur Heart J 2007;0:ehm236v1-75.
FULL TEXT
Treatment of Hypertension in the Prevention and Management of Ischemic Heart Disease: A Scientific Statement From the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention
Rosendorff et al.
Circulation 2007;115:2761-2788.
FULL TEXT
Long-Term Safety of a Novel Antianginal Agent in Patients With Severe Chronic Stable Angina: The Ranolazine Open Label Experience (ROLE)
Koren et al.
J Am Coll Cardiol 2007;49:1027-1034.
ABSTRACT
| FULL TEXT
Review: Angiotensin-converting enzyme inhibitors and coronary heart disease prevention
Donnelly and Manning
Journal of Renin-Angiotensin-Aldosterone System 2007;8:13-22.
ABSTRACT
The development of heart failure in patients with stable angina pectoris
Sutton et al.
Eur J Heart Fail 2007;9:234-242.
ABSTRACT
| FULL TEXT
Diastolic Blood Pressure in Coronary Artery Disease
Weber et al.
ANN INTERN MED 2007;146:149-149.
FULL TEXT
Standards of Medical Care in Diabetes--2007
American Diabetes Association
Diabetes Care 2007;30:S4-S41.
FULL TEXT
Prevalence, Awareness, Treatment, and Control of Hypertension Among United States Adults 1999-2004
Ong et al.
Hypertension 2007;49:69-75.
ABSTRACT
| FULL TEXT
The Cardiovascular Disease Continuum Validated: Clinical Evidence of Improved Patient Outcomes: Part I: Pathophysiology and Clinical Trial Evidence (Risk Factors Through Stable Coronary Artery Disease)
Dzau et al.
Circulation 2006;114:2850-2870.
FULL TEXT
New-onset diabetes mellitus less deadly than elevated blood pressure?: following the evidence in the administration of thiazide diuretics.
Phillips
Arch Intern Med 2006;166:2174-2176.
FULL TEXT
Progress and problems for randomized clinical trials: from streptomycin to the era of megatrials
Hilbrich and Sleight
Eur Heart J 2006;27:2158-2164.
ABSTRACT
| FULL TEXT
Lowering of Blood Pressure--The Lower, the Better?: Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous? Ann Intern Med 144: 884-893, 2006
Messerli et al.
J. Am. Soc. Nephrol. 2006;17:2345-2352.
FULL TEXT
Optimal Blood Pressure Levels in Patients With Coronary Artery Disease
Tobis and Fonarow
J Am Coll Cardiol 2006;48:839-840.
FULL TEXT
Antihypertensive treatment with beta-blockers and the spectrum of glycaemic control
Sarafidis and Bakris
QJM 2006;99:431-436.
ABSTRACT
| FULL TEXT
Dogma Disputed: Can Aggressively Lowering Blood Pressure in Hypertensive Patients with Coronary Artery Disease Be Dangerous?
Messerli et al.
ANN INTERN MED 2006;144:884-893.
ABSTRACT
| FULL TEXT
Blood Pressure Reduction Is Not the Only Determinant of Outcome
Sever et al.
Circulation 2006;113:2754-2774.
FULL TEXT
Re-examining the efficacy of {beta}-blockers for the treatment of hypertension: a meta-analysis
Khan and McAlister
CMAJ 2006;174:1737-1742.
ABSTRACT
| FULL TEXT
Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology
Authors/Task Force Members et al.
Eur Heart J 2006;27:1341-1381.
FULL TEXT
Effect of Antihypertensive Agents on the Development of Type 2 Diabetes Mellitus
Stump et al.
Mayo Clin Proc. 2006;81:796-806.
ABSTRACT
| FULL TEXT
Role of Diuretics in the Prevention of Heart Failure: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Davis et al.
Circulation 2006;113:2201-2210.
ABSTRACT
| FULL TEXT
Antihypertensive Therapy and the Risk of New-Onset Diabetes
Sarafidis and Bakris
Diabetes Care 2006;29:1167-1169.
FULL TEXT
Recent Trials in Hypertension: Compelling Science or Commercial Speech?
Psaty et al.
JAMA 2006;295:1704-1706.
FULL TEXT
Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease.
Thornley-Brown et al.
Arch Intern Med 2006;166:797-805.
ABSTRACT
| FULL TEXT
Depressive Symptoms in Coronary Artery Disease Patients After Hypertension Treatment
Ried et al.
The Annals of Pharmacotherapy 2006;40:597-604.
ABSTRACT
| FULL TEXT
Thiazide Diuretics in the Treatment of Hypertension: An Update
Salvetti and Ghiadoni
J. Am. Soc. Nephrol. 2006;17:S25-S29.
ABSTRACT
| FULL TEXT
Chronic Kidney Disease as a Situation of High Added Risk in Hypertensive Patients
Segura et al.
J. Am. Soc. Nephrol. 2006;17:S136-S140.
ABSTRACT
| FULL TEXT
Role of Angiotensin II in Cardiovascular Disease -- Therapeutic Implications of More Than a Century of Research
Ferrario
Journal of Renin-Angiotensin-Aldosterone System 2006;7:3-14.
ABSTRACT
Statin and beta-blocker therapy and the initial presentation of coronary heart disease.
Go et al.
ANN INTERN MED 2006;144:229-238.
ABSTRACT
| FULL TEXT
Predictors of Adverse Outcome Among Patients With Hypertension and Coronary Artery Disease
Pepine et al.
J Am Coll Cardiol 2006;47:547-551.
ABSTRACT
| FULL TEXT
Favourable long term prognosis in stable angina pectoris: an extended follow up of the angina prognosis study in Stockholm (APSIS)
Hjemdahl et al.
Heart 2006;92:177-182.
ABSTRACT
| FULL TEXT
Ranolazine is associated with cardiovascular and metabolic improvement: a win-win for patients with diabetes
Cooper-DeHoff and Pepine
Eur Heart J 2006;27:5-6.
FULL TEXT
Kidney-Heart Interactions: Epidemiology, Pathogenesis, and Treatment
Berl and Henrich
CJASN 2006;1:8-18.
FULL TEXT
Standards of Medical Care in Diabetes-2006
American Diabetes Association
Diabetes Care 2006;29:S4-S42.
FULL TEXT
JBS 2: Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice
Prepared by: British Cardiac Society, British Hype
Heart 2005;91:v1-v52.
FULL TEXT
Calcium Antagonists: Effects on Cardio-Renal Risk in Hypertensive Patients
Nathan et al.
Hypertension 2005;46:637-642.
ABSTRACT
| FULL TEXT
Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers for Prevention of Type 2 Diabetes: A Meta-Analysis of Randomized Clinical Trials
Abuissa et al.
J Am Coll Cardiol 2005;46:821-826.
ABSTRACT
| FULL TEXT
An Updated Meta-Analysis With a Few Surprises
Kaplan
Hypertension 2005;46:257-258.
FULL TEXT
Angiotensin-Converting Enzyme Inhibitors and Calcium Channel Blockers for Coronary Heart Disease and Stroke Prevention
Verdecchia et al.
Hypertension 2005;46:386-392.
ABSTRACT
| FULL TEXT
Impact of Achieved Blood Pressure on Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial
Berl et al.
J. Am. Soc. Nephrol. 2005;16:2170-2179.
ABSTRACT
| FULL TEXT
Clinical Outcomes in Antihypertensive Treatment of Type 2 Diabetes, Impaired Fasting Glucose Concentration, and Normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Whelton et al.
Arch Intern Med 2005;165:1401-1409.
ABSTRACT
| FULL TEXT
Review: atenolol may be ineffective for reducing cardiovascular morbidity or all cause mortality in hypertension
Cruickshank
Evid. Based Med. 2005;10:74-74.
FULL TEXT
A Study of Antihypertensive Drugs and Depressive Symptoms (SADD-Sx) in Patients Treated With a Calcium Antagonist Versus an Atenolol Hypertension Treatment Strategy in the International Verapamil SR-Trandolapril Study (INVEST)
Ried et al.
Psychosom. Med. 2005;67:398-406.
ABSTRACT
| FULL TEXT
Recent hypertension trials: Implications and controversies
Williams
J Am Coll Cardiol 2005;45:813-827.
ABSTRACT
| FULL TEXT
Update in Nephrology and Hypertension
Vidt
ANN INTERN MED 2005;142:433-438.
FULL TEXT
A Systematic Review of Drug Therapy to Delay or Prevent Type 2 Diabetes
Padwal et al.
Diabetes Care 2005;28:736-744.
ABSTRACT
| FULL TEXT